ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,525Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 79

$375K Total Retail Price of All Prescriptions

Rank: 6 out of 79

721 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 721 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

16% of this provider’s 721 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 11,065 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$30 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,017 914 1 1
LISINOPRIL 1,001 913 2 3
OMEPRAZOLE 582 518 3 5
LEVOTHYROXINE SODIUM 525 455 4 4
HYDROCODONE-ACETAMINOPHEN 491 388 S3 5 2
AMLODIPINE BESYLATE 385 369 6 6
LOVASTATIN 257 247 7 14
ATENOLOL 248 214 8 28
METFORMIN HCL 244 210 9 7
METOPROLOL TARTRATE 223 192 10 18
ZOLPIDEM TARTRATE 208 194 11 10
ALENDRONATE SODIUM 194 180 12 24
HYDROCHLOROTHIAZIDE 182 159 13 13
TRIAMTERENE-HCTZ 180 177 14 65
FUROSEMIDE 174 162 15 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 166 160 16 41
VENTOLIN HFA 162 142 17 32
GLYBURIDE 152 132 R 18 74
POTASSIUM CHLORIDE 150 146 19 29
GEMFIBROZIL 150 131 19 75
SERTRALINE HCL 144 112 21 38
METOPROLOL SUCCINATE 143 124 22 23
WARFARIN SODIUM 142 140 23 8
RANITIDINE HCL 142 113 23 46
DILTIAZEM ER 127 119 25 87
CLONIDINE HCL 127 111 25 87
LOSARTAN POTASSIUM 124 124 27 11
OXYBUTYNIN CHLORIDE 93 71 28 99
FLUTICASONE PROPIONATE 92 80 29 17
TERAZOSIN HCL 91 91 30 100
ALLOPURINOL 85 85 31 39
NIFEDIPINE ER 84 80 32 102
FENOFIBRATE 81 57 33 105
EVISTA 81 68 33 105
GABAPENTIN 77 61 35 15
CLOPIDOGREL 77 75 35 56
OXYCODONE HCL-ACETAMINOPHEN 77 68 S2 35 31
GLIPIZIDE 76 71 38 76
IBUPROFEN 70 66 39 114
PREDNISONE 70 69 39 20
FLUOXETINE HCL 67 43 41 54
OXYCODONE HCL 64 26 S2 42 12
OXYCODONE-ACETAMINOPHEN 62 46 S2 43 84
PLAVIX 60 60 44 66
BACLOFEN 60 25 44 126
AZITHROMYCIN 57 51 46 26
ESTRADIOL 55 45 R 47 95
FINASTERIDE 55 55 47 86
CIPROFLOXACIN HCL 54 50 49 51
CITALOPRAM HBR 54 52 49 30
COMBIVENT 53 52 51 57
CARVEDILOL 51 44 52 36
NIFEDICAL XL 51 51 52 141
NIFEDIAC CC 51 50 52 141
ISOSORBIDE MONONITRATE ER 51 51 52 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.